International Stem Cell Statistics
Want to see ISCO full AI Analyst Report?
International Stem Cell (ISCO) Stock Statistics & Valuation Metrics
Total Valuation
International Stem Cell has a market cap or net worth of $1.27M. The enterprise value is $3.95T.
- Market Cap
- $1.27M
- Enterprise Value
- $3.95T
Share Statistics
International Stem Cell has 8,004,389 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,004,389
- Owned by Insiders
- 0.06%
- Owned by Institutions
- <0.01%
Financial Efficiency
International Stem Cell’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -6.72%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- -0.09
- Return on Invested Capital (ROIC)
- -6.72%
- Return on Capital Employed (ROCE)
- -1.11
- Revenue Per Employee
- 275.76K
- Profits Per Employee
- -12.67K
- Employee Count
- 33
- Asset Turnover
- 1.89
- Inventory Turnover
- 2.66
Valuation Ratios
The current PE Ratio of International Stem Cell is -2.55. International Stem Cell’s PEG ratio is 0.01.
- PE Ratio
- -2.55
- PS Ratio
- 0.13
- PB Ratio
- 17.79
- Price to FCF
- 3.85
- Price to Operating Cash Flow
- 3.47
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, International Stem Cell had revenue of 9.10M and earned -418.00K in profits. Earnings per share was -0.05.
- Revenue
- 9.10M
- Gross Profit
- 5.07M
- Operating Income
- -267.00K
- Pretax Income
- -418.00K
- Net Income
- -418.00K
- EBITDA
- -48.00K
- Earnings Per Share (EPS)
- -0.05
Cash Flow
In the last 12 months, operating cash flow was 369.00K and capital expenditures -36,000, giving a free cash flow of 333.00K billion.
- Operating Cash Flow
- 369.00K
- Free Cash Flow
- 333.00K
- Free Cash Flow per Share
- 0.04
Dividends & Yields
International Stem Cell pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 26.00%
- Earnings Yield
- -45.44%
Stock Price Statistics
- Beta
- -0.96
- 52-Week Price Change
- 16.55%
- 50-Day Moving Average
- 0.26
- 200-Day Moving Average
- 0.22
- Relative Strength Index (RSI)
- 39.71
- Average Volume (3m)
- 38.22K
Financial Position
International Stem Cell as a current ratio of 0.74, with Debt / Equity ratio of -91.95%
- Current Ratio
- 0.74
- Quick Ratio
- 0.41
- Debt to Market Cap
- 2.98
- Net Debt to EBITDA
- -57.08
- Interest Coverage Ratio
- -1.77
Taxes
In the past 12 months, International Stem Cell has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
International Stem Cell EV to EBITDA ratio is -22.51, with an EV/FCF ratio of 10.95.
- EV to Sales
- 0.38
- EV to EBITDA
- -22.51
- EV to Free Cash Flow
- 10.95
- EV to Operating Cash Flow
- 9.88
Balance Sheet
International Stem Cell has $1.09M in cash and marketable securities with $3.46M in debt, giving a net cash position of -$2.37M billion.
- Cash & Marketable Securities
- $1.09M
- Total Debt
- $3.46M
- Net Cash
- -$2.37M
- Net Cash Per Share
- -$0.30
- Tangible Book Value Per Share
- -$0.06
Margins
Gross margin is 54.85%, with operating margin of -3.50%, and net profit margin of -6.12%.
- Gross Margin
- 54.85%
- Operating Margin
- -3.50%
- Pretax Margin
- -6.12%
- Net Profit Margin
- -6.12%
- EBITDA Margin
- -1.70%
- EBIT Margin
- -3.50%
Analyst Forecast
The average price target for International Stem Cell is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 3.40%
- EPS Growth Forecast
- -101.06%
Scores
- Smart Score
- ―
- AI Score
- 49

